(3S)-3-[[(2S)-2-[[(2S)-2-[[(2S,5S,8S,14S)-14-[[(2S)-1-[(2S)-2-acetamido-3-methyl-butanoyl]pyrrolidine-2-carbonyl]amino]-2-(3-amino-3-oxo-propyl)-5-benzyl-3,6,15-trioxo-1,4,7-triazacyclopentadecane-8-carbonyl]amino]-3-carboxy-propanoyl]amino]propanoyl]amino]-4-amino-4-oxo-butanoic acid

ID: ALA5219517

Chembl Id: CHEMBL5219517

PubChem CID: 168298330

Max Phase: Preclinical

Molecular Formula: C46H67N11O15

Molecular Weight: 1014.10

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H]1CCCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(N)=O)NC1=O)C(C)C

Standard InChI:  InChI=1S/C46H67N11O15/c1-23(2)37(50-25(4)58)46(72)57-19-11-16-33(57)45(71)53-28-15-10-6-9-14-27(41(67)56-32(22-36(62)63)43(69)49-24(3)39(65)54-30(38(48)64)21-35(60)61)51-44(70)31(20-26-12-7-5-8-13-26)55-42(68)29(52-40(28)66)17-18-34(47)59/h5,7-8,12-13,23-24,27-33,37H,6,9-11,14-22H2,1-4H3,(H2,47,59)(H2,48,64)(H,49,69)(H,50,58)(H,51,70)(H,52,66)(H,53,71)(H,54,65)(H,55,68)(H,56,67)(H,60,61)(H,62,63)/t24-,27-,28-,29-,30-,31-,32-,33-,37-/m0/s1

Standard InChI Key:  OYZWCBHNXUMCPU-XTDTXPIQSA-N

Alternative Forms

  1. Parent:

    ALA5219517

    ---

Associated Targets(Human)

PRMT5 Tchem PRMT5/MEP50 complex (963 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1014.10Molecular Weight (Monoisotopic): 1013.4818AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Krzyzanowski A, Esser LM, Willaume A, Prudent R, Peter C, 't Hart P, Waldmann H..  (2022)  Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.,  65  (22.0): [PMID:36378254] [10.1021/acs.jmedchem.2c01273]

Source